menu

Why You Should Continue Co-testing for Cervical Cancer: A Summary of Studies

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Why You Should Continue Co-testing for Cervical Cancer: A Summary of Studies

    Linking the current cervical cancer screening guidelines to clinical evidence to inform optimal patient care.
    • Sponsored by

    • Overview

      Linking the current cervical cancer screening guidelines to clinical evidence to inform optimal patient care.

      Summary of Recommendations:

      • Maintain Pap plus HPV together (co-testing) as the preferred method for cervical cancer screening in women ≥30 years old
      • Change the interval for co-testing women ≥30 years old from every 5 years to every 3 years
      • Recommend that women 21 years of age begin cervical cancer screening with Pap testing every 3 years and not begin HPV screening until ≥30 years old

    Facebook Comments

    You must be in to display playlists.

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.